KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance
Cell Reports · 2023-11 · 42 (11) · 113295
DOI: 10.1016/j.celrep.2023.113295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023-11. Verfasst von Anastasia-Maria Zavitsanou und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA; Vilcek Institute of Graduate Biomedical Sciences, NYU Grossman School of…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 172-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA; Vilcek Institute of Graduate Biomedical Sciences, NYU Grossman School of Medicine, New York, NY, USA.
- Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, VA New York Harbor Healthcare System, New York, NY, USA; Division of…
- Applied Bioinformatics Laboratories, NYU Grossman School of Medicine, New York, NY, USA; Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, USA.
- Vilcek Institute of Graduate Biomedical Sciences, NYU Grossman School of Medicine, New York, NY, USA; Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA.
- Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA.
- Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA; Department of Immunology and Microbial Pathogenesis, Weill Cornell Medical College, New York, NY, USA.
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- NHLBI NIH HHS
- NIGMS NIH HHS
- Agios Pharmaceuticals
- Stanford Genome Technology Center
- LEO Fondet
- Cancer Center, University of Colorado
Zitieren
APA
Zavitsanou, A. M., Pillai, R., Hao, Y., Wu, W. L., Bartnicki, E., Karakousi, T., Rajalingam, S., Herrera, A., Karatza, A., Rashidfarrokhi, A., Solis, S., Ciampricotti, M., Yeaton, A. H., Ivanova, E., Wohlhieter, C. A., Buus, T. B., Hayashi, M., Karadal-Ferrena, B., Pass, H. I., …, & Koralov, S. B. (2023). KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance. Cell Reports, 42(11), 113295. https://doi.org/10.1016/j.celrep.2023.113295
Vancouver
Zavitsanou AM, Pillai R, Hao Y, Wu WL, Bartnicki E, Karakousi T, et al. KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance. Cell Reports. 2023;42(11):113295. doi:10.1016/j.celrep.2023.113295
BibTeX
@article{Zavitsanou2023,
author = {Zavitsanou, Anastasia-Maria and Pillai, Ray and Hao, Yuan and Wu, Warren L and Bartnicki, Eric and Karakousi, Triantafyllia and Rajalingam, Sahith and Herrera, Alberto and Karatza, Angeliki and Rashidfarrokhi, Ali and Solis, Sabrina and Ciampricotti, Metamia and Yeaton, Anna H and Ivanova, Ellie and Wohlhieter, Corrin A and Buus, Terkild B and Hayashi, Makiko and Karadal-Ferrena, Burcu and Pass, Harvey I and Poirier, John T and Rudin, Charles M and Wong, Kwok-Kin and Moreira, Andre L and Khanna, Kamal M and Tsirigos, Aristotelis and Papagiannakopoulos, Thales and Koralov, Sergei B},
title = {KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance},
journal = {Cell Reports},
year = {2023},
volume = {42},
number = {11},
pages = {113295},
doi = {10.1016/j.celrep.2023.113295}
}
EUVIMED